119 related articles for article (PubMed ID: 35876345)
1. Introduction of Fluorine into Antitumor-Active Dinuclear Platinum(II) Complexes Leads to Modulation of
Uemura M; Hiramoto K; Yoneyama H; Harusawa S; Komeda S
Inorg Chem; 2022 Aug; 61(31):12155-12164. PubMed ID: 35876345
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
Komeda S; Takayama H; Suzuki T; Odani A; Yamori T; Chikuma M
Metallomics; 2013 May; 5(5):461-8. PubMed ID: 23608770
[TBL] [Abstract][Full Text] [Related]
3. Specific Conformational Change in Giant DNA Caused by Anticancer Tetrazolato-Bridged Dinuclear Platinum(II) Complexes: Middle-Length Alkyl Substituents Exhibit Minimum Effect.
Komeda S; Yoneyama H; Uemura M; Muramatsu A; Okamoto N; Konishi H; Takahashi H; Takagi A; Fukuda W; Imanaka T; Kanbe T; Harusawa S; Yoshikawa Y; Yoshikawa K
Inorg Chem; 2017 Jan; 56(2):802-811. PubMed ID: 28045514
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity relationships of tetrazolato-bridged dinuclear platinum(II) complexes: A small modification at tetrazole C5 markedly influences the in vivo antitumor efficacy.
Komeda S; Yoneyama H; Uemura M; Tsuchiya T; Hoshiyama M; Sakazaki T; Hiramoto K; Harusawa S
J Inorg Biochem; 2019 Mar; 192():82-86. PubMed ID: 30612029
[TBL] [Abstract][Full Text] [Related]
5. Highly efficient uptake into cisplatin-resistant cells and the isomerization upon coordinative DNA binding of anticancer tetrazolato-bridged dinuclear platinum(II) complexes.
Uemura M; Hoshiyama M; Furukawa A; Sato T; Higuchi Y; Komeda S
Metallomics; 2015 Nov; 7(11):1488-96. PubMed ID: 26393664
[TBL] [Abstract][Full Text] [Related]
6. An in vivo highly antitumor-active tetrazolato-bridged dinuclear platinum(II) complex largely circumvents in vitro cisplatin resistance: two linkage isomers yield the same product upon reaction with 9-ethylguanine but exhibit different cytotoxic profiles.
Uemura M; Suzuki T; Nishio K; Chikuma M; Komeda S
Metallomics; 2012 Jul; 4(7):686-92. PubMed ID: 22473092
[TBL] [Abstract][Full Text] [Related]
7. A novel isomerization on interaction of antitumor-active azole-bridged dinuclear platinum(II) complexes with 9-ethylguanine. Platinum(II) atom migration from N2 to N3 on 1,2,3-triazole.
Komeda S; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
J Am Chem Soc; 2002 May; 124(17):4738-46. PubMed ID: 11971723
[TBL] [Abstract][Full Text] [Related]
8. Highly efficient DNA compaction mediated by an in vivo antitumor-active tetrazolato-bridged dinuclear platinum(II) complex.
Yoshikawa Y; Komeda S; Uemura M; Kanbe T; Chikuma M; Yoshikawa K; Imanaka T
Inorg Chem; 2011 Nov; 50(22):11729-35. PubMed ID: 22004345
[TBL] [Abstract][Full Text] [Related]
9. Second- and higher-order structural changes of DNA induced by antitumor-active tetrazolato-bridged dinuclear platinum(II) complexes with different types of 5-substituent.
Uemura M; Yoshikawa Y; Yoshikawa K; Sato T; Mino Y; Chikuma M; Komeda S
J Inorg Biochem; 2013 Oct; 127():169-74. PubMed ID: 23725767
[TBL] [Abstract][Full Text] [Related]
10. Kinetic analysis of and platinum(II) migration in the reactions of tetrazolato-bridged dinuclear platinum(II) complexes with nucleotides.
Uemura M; Komeda S
J Inorg Biochem; 2017 Dec; 177():359-367. PubMed ID: 28893417
[TBL] [Abstract][Full Text] [Related]
11. Data on synthesis and structure-activity relationships of tetrazolato-bridged dinuclear platinum(II) complexes.
Komeda S; Yoneyama H; Uemura M; Tsuchiya T; Hoshiyama M; Sakazaki T; Hiramoto K; Harusawa S
Data Brief; 2022 Feb; 40():107697. PubMed ID: 34993284
[TBL] [Abstract][Full Text] [Related]
12. [Drug discovery research in in-vivo antitumor-active azolato-bridged dinuclear Pt(II) complexes].
Komeda S
Yakugaku Zasshi; 2012; 132(3):253-9. PubMed ID: 22382827
[TBL] [Abstract][Full Text] [Related]
13. New antitumor-active azole-bridged dinuclear platinum(II) complexes: synthesis, characterization, crystal structures, and cytotoxic studies.
Komeda S; Lutz M; Spek AL; Chikuma M; Reedijk J
Inorg Chem; 2000 Sep; 39(19):4230-6. PubMed ID: 11196916
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of series of diazine-bridged dinuclear platinum(II) complexes through in vitro toxicity and molecular modeling: correlation between structure and activity of Pt(II) complexes.
Senerovic L; Zivkovic MD; Veselinovic A; Pavic A; Djuran MI; Rajkovic S; Nikodinovic-Runic J
J Med Chem; 2015 Feb; 58(3):1442-51. PubMed ID: 25551180
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro and in vivo antitumor activity of a series of trans platinum antitumor complexes.
Kelland LR; Barnard CF; Evans IG; Murrer BA; Theobald BR; Wyer SB; Goddard PM; Jones M; Valenti M; Bryant A
J Med Chem; 1995 Aug; 38(16):3016-24. PubMed ID: 7636864
[TBL] [Abstract][Full Text] [Related]
16. Chromatin folding and DNA replication inhibition mediated by a highly antitumor-active tetrazolato-bridged dinuclear platinum(II) complex.
Imai R; Komeda S; Shimura M; Tamura S; Matsuyama S; Nishimura K; Rogge R; Matsunaga A; Hiratani I; Takata H; Uemura M; Iida Y; Yoshikawa Y; Hansen JC; Yamauchi K; Kanemaki MT; Maeshima K
Sci Rep; 2016 Apr; 6():24712. PubMed ID: 27094881
[TBL] [Abstract][Full Text] [Related]
17. Intracellular uptake of an antitumor-active azole-bridged dinuclear platinum(II) complex in cisplatin-resistant tumor cells.
Kishimoto S; Yasuda M; Suzuki R; Fukushima S
Biometals; 2016 Dec; 29(6):1075-1083. PubMed ID: 27787693
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo anti-tumor effects of selected platinum(IV) and dinuclear platinum(II) complexes against lung cancer cells.
Arsenijevic M; Milovanovic M; Jovanovic S; Arsenijevic N; Markovic BS; Gazdic M; Volarevic V
J Biol Inorg Chem; 2017 Aug; 22(6):807-817. PubMed ID: 28421385
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
[TBL] [Abstract][Full Text] [Related]
20. Dinuclear Platinum(II) Complexes with Bone-Targeting Groups as Potential Anti-Osteosarcoma Agents.
Zhang Z; Wang X; Luo C; Zhu C; Wang K; Zhang C; Guo Z
Chem Asian J; 2017 Jul; 12(13):1659-1667. PubMed ID: 28556606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]